Scarica l'app Stockscreener
0.00
100.00%
-0.1973
Precedente Chiudi:
$0.1973
Aprire:
$0
Volume 24 ore:
0
Relative Volume:
0.00
Capitalizzazione di mercato:
$13.07M
Reddito:
-
Utile/perdita netta:
$-11.11M
Rapporto P/E:
0.00
EPS:
-2.4155
Flusso di cassa netto:
-
1 W Prestazione:
-100.00%
1M Prestazione:
-100.00%
6M Prestazione:
-100.00%
1 anno Prestazione:
-100.00%
Intervallo 1D:
$0.00
$0.00
Intervallo di 1 settimana:
$0.00
$0.00
Portata 52W:
$0.00
$2.93
Carmell Corp Stock (CTCX) Company Profile
Nome
Carmell Corp
Settore
Industria
Telefono
412-894-8248
Indirizzo
2403 SIDNEY STREET, SUITE 300, PITTSBURGH
Confronta CTCX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CTCX
Carmell Corp
|
0.00 | 13.07M | 0 | -11.11M | 0 | -2.4155 |
|
PG
Procter Gamble Co
|
161.66 | 388.61B | 83.93B | 15.50B | 15.03B | 6.30 |
|
UL
Unilever Plc Adr
|
63.01 | 156.39B | 65.10B | 6.16B | 0 | 2.4569 |
|
CL
Colgate Palmolive Co
|
92.30 | 76.81B | 20.10B | 2.89B | 3.55B | 3.52 |
|
KMB
Kimberly Clark Corp
|
130.43 | 46.48B | 19.75B | 2.47B | 2.39B | 7.34 |
|
KVUE
Kenvue Inc
|
23.27 | 42.73B | 15.46B | 1.03B | 1.34B | 0.53 |
Carmell Corp Borsa (CTCX) Ultime notizie
Carmell (NASDAQ:CTCX) vs. Dynatronics (NASDAQ:DYNT) Financial Contrast - Defense World
Head to Head Review: Tandem Diabetes Care (NASDAQ:TNDM) versus Carmell (NASDAQ:CTCX) - Defense World
Carmell (NASDAQ:CTCX) Trading Down 3.1% – What’s Next? - Defense World
South Side biotech company Longevity Health Holdings announces merger plans - The Business Journals
Longevity Health Holdings Announces Execution Of Merger Agreement With 20/20 Biolabs - marketscreener.com
SEC Form 424B5 filed by Longevity Health Holdings Inc. - Quantisnow
Longevity Health Holdings Announces Execution of Merger Agreement With 20/20 Biolabs - GlobeNewswire
Carmell (NASDAQ:CTCX) Shares Down 8.5% – Here’s What Happened - Defense World
Carmell Corporation changes name to Longevity Health Holdings - Pennsylvania Business Report -
Local biotech company rebrands as Longevity Health Holdings - The Business Journals
CARMELL CORP REBRANDS AS LONGEVITY HEALTH HOLDINGS TO - GlobeNewswire
CARMELL CORP REBRANDS AS LONGEVITY HEALTH HOLDINGS TO HIGHLIGHT BUSINESS FOCUS & GROWTH STRATEGY - The Bakersfield Californian
Carmell Transforms Into Longevity Health Holdings Amid Strong Growth - StockTitan
Carmell Stock Price, Quotes and Forecasts | NASDAQ:CTCX - Benzinga
CTCX stock touches 52-week low at $0.2 amid market challenges - Investing.com
CTCX stock touches 52-week low at $0.2 amid market challenges By Investing.com - Investing.com South Africa
Carmell Corp announces CEO transition, appoints new leader - MSN
Carmell Corp (CTCX) Stock: A Year of Highs and Lows - The InvestChronicle
Market Resilience: Carmell Corp (CTCX) Finishes Weak at 0.32, Down -25.58 - The Dwinnex
Carmell Corp Files For Mixed Shelf Of Up To $100 Million -February 03, 2025 at 05:40 pm EST - Marketscreener.com
Neumora Therapeutics, Rain Oncology, and Carmell Corporation: Stock Volatility Highlights Major Market Moves - HPBL
Carmell Closes Purchase of Elevai Skincare - Orange County Business Journal
Carmell Corp announces CEO transition, appoints new leader By Investing.com - Investing.com South Africa
Carmell Corporation Announces CEO Changes -January 24, 2025 at 05:00 pm EST - Marketscreener.com
Carmell Therapeutics Announces Leadership Transition and New CEO - TipRanks
South Side biotech firm Carmell Therapeutics acquires skincare companyPittsburgh Business Times - The Business Journals
PMGC Holdings Inc. Announces Closing of Elevai Skincare Divestiture - Yahoo Finance
Carmell Announces Closing of Elevai Skincare Acquisition - The Manila Times
Carmell Acquires Elevai Skincare in $1.1M Stock Deal, Expanding Beauty Portfolio - StockTitan
Carmell Cosmetics introduces bio-aesthetic skin care with regenerative technology - Cosmetics Design North America
Carmell, Mustang Bio, Revelation Biosciences Dominate Retail Biotech Talk As 2025 Kicks Off - MSN
Carmell's earning potential swells with Elevai acquisition - MSN
Carmell Corporation to Acquire Physician-Dispensed Elevai Skincare - BeautyMatter
Nasdaq Surges Over 1%; Cerence Shares Spike Higher - Benzinga
Carmell Closes PIPE Investment from Existing and New Investors - citybiz
Dow Jumps Over 100 Points; ISM Manufacturing PMI Increases In December - Benzinga
Carmell Therapeutics Secures $1.85M Private Placement to Fuel Bio-Aesthetic Growth Strategy - StockTitan
Carmell acquires Elevai SkincareFashionNetwork - FashionNetwork - The World's Fashion Business News
PMGC Holdings Inc. Following Skincare Subsidiary Sale, Embarks on Bold Growth Strategy - GlobeNewswire Inc.
Cardill More Than Doubles On Acquisition - MENAFN.COM
Crude Oil Surges 2%; Tesla Shares Plummet - Benzinga
Carmell To Acquire Elevai Skincare - citybiz
CopperU.S. STOCKS ON THE MOVE-Tesla, Copper Miners, Natgas Firms - eFXdata
Carmell's earning potential swells with Elevai acquisition (CTCX) - Seeking Alpha
Cardill More than Doubles on Acquisition - Baystreet.ca
Wall Street Today: US stocks open higher after markets reopen post New Year; Tesla shares down 7% on low delivery data | Stock Market News - Mint
Carmell Corp Azioni (CTCX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Carmell Corp Azioni (CTCX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Gregory Kathryn | Director |
Sep 06 '24 |
Buy |
0.51 |
1,260 |
643 |
22,500 |
| Sturgeon Patrick A | Director |
Sep 06 '24 |
Buy |
0.51 |
1,261 |
643 |
18,051 |
| Cassaday Bryan J. | Chief Financial Officer |
Sep 10 '24 |
Buy |
0.46 |
475 |
218 |
4,250 |
| Frisch Scott M. | Director |
Sep 06 '24 |
Buy |
0.51 |
1,009 |
515 |
7,598 |
| Spenlehauer Gilles | Director |
Sep 06 '24 |
Buy |
0.51 |
1,009 |
515 |
7,598 |
| Gregory Kathryn | Director |
Aug 30 '24 |
Buy |
0.57 |
109 |
62 |
21,240 |
| Frisch Scott M. | Director |
Aug 30 '24 |
Buy |
0.57 |
87 |
50 |
6,589 |
| Sturgeon Patrick A | Director |
Aug 30 '24 |
Buy |
0.57 |
109 |
62 |
16,790 |
| Spenlehauer Gilles | Director |
Aug 30 '24 |
Buy |
0.57 |
87 |
50 |
6,589 |
| Sturgeon Patrick A | Director |
Aug 28 '24 |
Buy |
0.56 |
970 |
543 |
16,029 |
0.30%
0.46%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):